Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer

NCT02115152 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Stage II Breast Cancer
Stage III Breast Cancer

Interventions

DRUG: fluorouracil
DRUG: capecitabine
DRUG: cyclophosphamide
DRUG: Epirubicin

Sponsor

Guangxi Medical University